Recombinant growth hormone for children and adolescents with Turner syndrome: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Growth Hormone for Children and Adolescents With Turner Syndrome: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433915/0/Treatment_for_Lambert‐Eaton_myasthenic_syndrome_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 20 April 2024.
Recombinant growth hormone for children and adolescents with Turner syndrome: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433915/0/Treatment_for_Lambert‐Eaton_myasthenic_syndrome_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed April 20, 2024.
Recombinant growth hormone for children and adolescents with Turner syndrome: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433915/0/Treatment_for_Lambert‐Eaton_myasthenic_syndrome_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Recombinant Growth Hormone for Children and Adolescents With Turner Syndrome: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433915/0/Treatment_for_Lambert‐Eaton_myasthenic_syndrome_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant growth hormone for children and adolescents with Turner syndrome: Cochrane systematic review
ID - 433915
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433915/0/Treatment_for_Lambert‐Eaton_myasthenic_syndrome_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -